Alliancebernstein L.P. Pacira Bio Sciences, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 52,894 shares of PCRX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,894

Previous 52,830 0.12%

Holding current value

$1.05 Million

Previous $1.51 Million 47.32%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $748 - $1,821	64 Added 0.12%	52,894 $796,000
Q1 2024 May 14, 2024	SELL	$27.7 - $35.48 $101,382 - $129,856	-3,660 Reduced 6.48%	52,830 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $1,947 - $2,538	-74 Reduced 0.13%	56,490 $1.91 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $726,717 - $949,611	-23,687 Reduced 29.52%	56,564 $1.74 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $47.5 $887,974 - $1.17 Million	24,584 Added 44.16%	80,251 $3.22 Million
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $3.79 Million - $4.63 Million	-106,769 Reduced 65.73%	55,667 $2.27 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $3.82 Million - $5.75 Million	100,049 Added 160.37%	162,436 $6.27 Million
Q3 2022 Nov 15, 2022	SELL	$51.24 - $58.89 $25,005 - $28,738	-488 Reduced 0.78%	62,387 $3.32 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $272,485 - $432,038	5,292 Added 9.19%	62,875 $3.67 Million
Q1 2022 May 13, 2022	SELL	$60.03 - $76.49 $1.01 Million - $1.29 Million	-16,859 Reduced 22.65%	57,583 $4.4 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $4,221 - $5,474	88 Added 0.12%	74,442 $4.48 Million
Q3 2021 Nov 10, 2021	SELL	$54.64 - $61.3 $131,136 - $147,120	-2,400 Reduced 3.13%	74,354 $4.16 Million
Q2 2021 Jul 30, 2021	BUY	$59.18 - $69.99 $216,598 - $256,163	3,660 Added 5.01%	76,754 $4.66 Million
Q1 2021 May 06, 2021	BUY	$59.31 - $78.82 $40,330 - $53,597	680 Added 0.94%	73,094 $5.12 Million
Q4 2020 Feb 08, 2021	SELL	$50.47 - $66.26 $15,141 - $19,878	-300 Reduced 0.41%	72,414 $4.33 Million
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $51,450 - $62,370	-990 Reduced 1.34%	72,714 $4.37 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $272,272 - $463,834	8,840 Added 13.63%	73,704 $3.87 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $1,420 - $2,535	50 Added 0.08%	64,864 $2.18 Million
Q4 2019 Feb 18, 2020	BUY	$36.31 - $46.83 $9,077 - $11,707	250 Added 0.39%	64,814 $2.94 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $268,662 - $338,954	7,534 Added 13.21%	64,564 $2.46 Million
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $44,495 - $64,396	-1,618 Reduced 2.76%	57,030 $1.83 Million
Q1 2018 May 14, 2018	BUY	$29.98 - $46.35 $12,531 - $19,374	418 Added 0.72%	58,648 $1.83 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $2.08 Million - $2.3 Million	58,230	58,230 $2.19 Million

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $911M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Pacira Bio Sciences, Inc. Transaction History